Search

Search Constraints

You searched for: Author/Creator Meinke, Peter T.

Search Results

1. Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors. Issue 20 (15th October 2016)

2. C1–C2-linker substituted 1, 5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7). Issue 10 (25th August 2015)

3. ChemInform Abstract: Syntheses of Nucleosides with 2′‐Spirolactam and 2′‐Spiropyrrolidine Moieties as Potential Inhibitors of Hepatitis C Virus NS5B Polymerase. Issue 50 (16th December 2014)

4. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti‐malaria Activity in Humanized Mice. (11th March 2021)

5. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti‐malaria Activity in Humanized Mice. Issue 17 (11th March 2021)

6. Development of a New Structural Class of Broadly Acting HCV Non‐Nucleoside Inhibitors Leading to the Discovery of MK‐8876. (25th July 2017)

7. Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity. Issue 13 (1st July 2016)

8. Discovery of MK‐8742: An HCV NS5A Inhibitor with Broad Genotype Activity. Issue 12 (14th October 2013)

9. Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis. Issue 16 (15th August 2016)

10. Front Cover: Development of a New Structural Class of Broadly Acting HCV Non‐Nucleoside Inhibitors Leading to the Discovery of MK‐8876 (ChemMedChem 17/2017). (13th September 2017)